Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$9,505,197
+$1,105,081 QoQ
Shares Held
37,773
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.87%
of 13F equity value
Holder Rank
#947
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN STRUM & TOWNE INC. holds $44,052,208 across 8 Drug Manufacturers - General names. ABBV ranks #3 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
44,632 | $11,335,189 | |
| 2 | AMGN |
Amgen Inc
|
31,250 | $11,316,250 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
37,773 | $9,505,197 | |
| 4 | LLY |
ELI LILLY & Co
|
5,679 | $6,811,563 | |
| 5 | PFE |
Pfizer Inc
|
85,044 | $2,047,859 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,293 | $1,708,150 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,392 | $944,507 | |
| 8 | NVS |
Novartis AG
|
2,447 | $383,493 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,505,197 | 37,773 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $8,400,116 | 38,623 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $8,886,661 | 38,893 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,181,024 | 39,652 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,579,607 | 40,834 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $8,779,726 | 41,904 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,911,108 | 38,892 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,259,326 | 31,696 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,425,349 | 31,631 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $5,783,496 | 31,760 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,959,040 | 32,000 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $4,784,826 | 32,100 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,384,787 | 32,545 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,184,306 | 32,530 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,285,455 | 32,705 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $4,404,772 | 32,820 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,078,632 | 33,159 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,363,409 | 33,085 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,377,482 | 32,330 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,387,118 | 31,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,474,944 | 30,850 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $3,363,477 | 31,080 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $3,159,317 | 29,485 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $2,530,037 | 28,885 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,816,784 | 28,690 | Shares | Defined | 2020-07-14 | |
| 2020-03-31 | $238,474 | 3,130 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||